Event

IAS 2023

Brisbane, Australia

The 12th International AIDS Society (IAS) Conference on HIV Science took place in person and virtually from 23-26 July. During the four-day conference, HPTN researchers presented 12 abstracts showcasing HPTN 082, HPTN 084, HPTN 084-01, HVTN 704/HPTN 085 (AMP), HVTN 805/HPTN 093, HVTN 804/HPTN 095, and the Statistical and Data Management Center (SDMC).

Hoping to Adhere? Examining the Relationship Between Hope and PrEP Willingness and Adherence Among Adolescent Girls and Young Women Enrolled in HIV Prevention Trial 082 – Margaret Gichane

Positive Predictive Value of HIV Serological Tests in HPTN 084 Trial – Mina Hosseinipour

Initial PrEP Product Choice: Results from the HPTN 084 Open-Label Extension – Sinead Delany-Moretlwe

“Should I have my nose close to his?'. Perspectives on the Effects of COVID-19 on Clinical Trial Participation and HIV Risk Among Women in HPTN 084 – Agatha Bula

Willingness to use Long-acting Injectable Cabotegravir (CAB-LA) or Oral TDF/FTC for Pre-Exposure Prophylaxis (PrEP) During Pregnancy in Africa: Findings from the HPTN 084 Qualitative Sub-Study – Juliane Etima

Acceptability of CAB-LA in Cisgender Female Adolescents in South Africa, Uganda, and Zimbabwe – erica hamilton

Challenges Faced by Adolescent Girls in Uganda that Affected Timely Delivery of HIV Prevention Services; Observational findings from HPTNO84- 01 Study at Kampala, MU-JHU Site – Miscah Babirye Otim

Parent/Guardians Knowledge, Attitudes and Perceptions on Long Acting Injectable Cabotegravir (CAB LA) for HIV Prevention and Study Participation in HPTN 084-01 study: Tales from Mu-JHU, Kampala Site – Emmie Mulumba

Association of HIV Pre-exposure Prophylaxis (PrEP) Use and Bacterial Sexually Transmitted Infections (bSTI) among Men who Have Sex with Men (MSM) and Transgender Women (TGW) in HVTN 704/HPTN 085 – Jorge Gallardo-Cartagena

Analytical Treatment Interruption Among African Women and Peruvian Men & Transgender Individuals with Early ART and Initiation +/- VRCO1 Circulating at HIV Acquisition: Early Observations of Viral Rebound 6 Control (HVTN 805/HPTN 093 and HVTN 804/HPTN 095) – Shelly Karuna

Novel Scientific Approaches for Establishing Efficacy of New Biologics in the Era of Long-acting PrEP – Deborah Donnell, HPTN SDMC

The Counterfactual Approach: Tools and Data Sources Available for Prevention Trials – Deborah Donnell, HPTN SDMC